m6A Modification-mediated GRAP Regulates Vascular Remodeling in Hypoxic Pulmonary Hypertension
Pengfei Liu,Aikai Zhang,Zheng Ding,Dongpu Dai,Boyan Li,Shao-Fei Liu,Jingjing Xu,Zhe Cheng,Song Zhao,Xiaoyan Zhao,Jianzeng Dong
DOI: https://doi.org/10.1165/rcmb.2021-0429oc
IF: 7.748
2022-11-02
American Journal of Respiratory Cell and Molecular Biology
Abstract:Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling induced by human pulmonary arterial smooth muscle cell (HPASMC) proliferation, migration, and apoptosis resistance. m 6 A ( N 6 -methyladenosine) is the most prevalent RNA posttranscriptional modification in eukaryotic cells. However, its role in PAH remains elusive. We designed this study to investigate whether m 6 A modification and its effector proteins play a role in pulmonary vascular resistance. Lung samples were used to profile m 6 A concentrations in control subjects and patients with PAH. Bioinformatics analysis, real-time PCR, immunohistochemistry, and Western blotting were used to determine the role of m 6 A effectors in PAH. The biological effects of GRAP modified by m 6 A were investigated using in vitro and in vivo models. Furthermore, RIP-PCR was used to assess the writers and readers of GRAP . In this study, we revealed that m 6 A-modified GRAP mRNA was upregulated in PAH lung samples, cHx/Su-induced mouse models, and hypoxia-stimulated HPASMCs; however, GRAP mRNA and protein were abnormally downregulated. Functionally, overexpression of GRAP drastically alleviated the proliferative and invasive ability of PAH HPASMCs through inhibition of the Ras/ERK signaling pathway in vitro and in vivo . In addition, METTL14 (methyltransferase-like 14) and the m 6 A binding protein YTHDF2 were significantly increased in PAH. Moreover, we found that m 6 A-modified GRAP mRNA was recognized by YTHDF2 to mediate the degradation. GRAP expression was consistently negatively correlated with METTL14 and YTHDF2 in vivo and in vitro . Taken together, for the first time, our findings highlight the function and therapeutic target value of GRAP and extend our understanding of the importance of RNA epigenetics in PAH.
biochemistry & molecular biology,cell biology,respiratory system